Skip to content
AllotarX™ platform

From Protein Dynamics to Precision Allosteric Discovery

AllotarX™ transforms protein conformational ensembles into actionable, selective allosteric sites, combining physics-based simulation, interpretable AI, and closed-loop validation to design safer, more precise therapeutics.

SCROLL
AllotarX™ workflow

One system, continuously improving

From dynamic protein ensembles to selective, validated therapeutics in a single closed-loop system.

  • Identify functional allosteric sites across ensembles
  • Prioritize pockets by mechanism and druggability
  • Link structure dynamics to functional outcomes
  • Design selective interventions
  • Validate function in biochemical and cell-based assays
  • Learn from every result
AllotarX™ engineloop · continuous
AllotarX™closed-loop
discovery
engine
Precision allosteryDesign
Selective hitsBuild
Functional validationTest
Refined trainingLearn
Design

Prioritized regulatory sites guide modality-specific design across small molecules, macrocyclic peptides and computationally designed scaffolds.

Build

Ensemble-guided libraries and focused candidates translate computational designs into testable interventions.

Test

Biochemical and cell-based assays evaluate function, binding and selectivity with partner laboratories.

Learn

Every outcome, whether hit or miss, refines predictions and guides the next design cycle.

Dynamics sampling

Ultra-Fast Dynamics Sampling

Maps protein conformational landscapes with over 1000× less compute than established enhanced-sampling workflows such as replica-exchange umbrella sampling applied to the same protein.

Enables end-to-end, ensemble-based drug discovery workflow.

Impact
  • Unlocks target dynamics and key transition states for precision allosteric control
  • Reveals cryptic sites and mechanisms underlying protein function and modulation
  • Scales to large multi-chain complexes and assemblies that conventional MD cannot sample long enough to reveal functional motions.
OpenMetastableClosedTransition state
Allosteric discovery

Allosteric Discovery with Selectivity-First Design

Identifies allosteric sites with 90% benchmarked accuracy across protein ensembles.

Introduces target selectivity from the earliest stages of discovery through interpretable AI integrating druggability, dynamics, and allosteric signatures.

Impact
  • Expands access to challenging targets through precise allosteric control.
  • Delivers selective modulators with reduced off-target risk and improved safety potential.
  • Reduces downstream attrition risk in optimization and clinical development.
Multi-site discovery

Multi-Site, Multi-Modality Discovery

Designs site-specific modalities (small molecules, macrocyclic peptides, computationally designed scaffolds) tailored to the dynamic and geometric features of each regulatory site.

Integrates experimental data on binding, function, and selectivity to continuously refine predictions and guide design.

Impact
  • Reduces optimization cycles and development timelines
  • Expands design options through site- and modality-specific strategies
  • Increases the likelihood of achieving desired functional activity and selectivity
Science at the Core

Built on peer-reviewed science

AllotarX™ builds on methods for protein dynamics and allosteric drug discovery developed and validated by our co-founders through extensive peer-reviewed research. The platform extends this scientific foundation with proprietary advances in scale, selectivity and closed-loop learning.

100+publications
5,000+citations
Selected publications 15 papersShow listHide list

Explore our dynamics-aware, lab-in-the-loop, multi-site and multi-modal approach